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43

ABSTRACT

44

Introduction. We performed the first analysis of heart rate variability (HRV) at rest

45

and exercise under full autonomic blockade on the same subjects, to test the

46

conjecture that vagal tone withdrawal occurs at exercise onset. We hypothesized

47

that, between rest and exercise: i) no differences in total power (PTOT) under

48

parasympathetic blockade; ii) a PTOT fall under 1-sympathetic blockade; iii) no

49

differences in PTOT under blockade of both ANS branches.

50

Methods. 7 males (24±3 years) performed 5-min cycling (80W) supine, preceded by

51

5-min rest during control and with administration of atropine, metoprolol and

52

atropine+metoprolol (double blockade). Heart rate and arterial blood pressure were

53

continuously recorded. HRV and blood pressure variability were determined by power

54

spectral analysis, and baroreflex sensitivity (BRS) by the sequence method.

55

Results. At rest, PTOT and the powers of low (LF) and high (HF) frequency

56

components of HRV were dramatically decreased in atropine and double blockade

57

compared to control and metoprolol, with no effects on LF/HF ratio and on the

58

normalised LF (LFnu) and HF (HFnu). At exercise, patterns were the same as at rest.

59

Comparing exercise to rest, PTOT varied as hypothesized. For SAP and DAP, resting

60

PTOT was the same in all conditions. At exercise, in all conditions, PTOT was lower

61

than in control. BRS decreased under atropine and double blockade at rest, under

62

control and metoprolol during exercise.

63

Conclusions. The results support the hypothesis that vagal suppression determined

64

disappearance of HRV during exercise.

65
66
67
68
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72
73

New & Noteworthy

74

This study provides the first demonstration, by systematic analysis of heart rate variability

75

(HRV) at rest and exercise under full autonomic blockade on the same subjects, that

76

suppression of vagal activity is responsible of the disappearance of spontaneous HRV during

77

exercise. This finding supports previous hypotheses on the role of vagal withdrawal in the

78

control of the rapid cardiovascular response at exercise onset.

79
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80

INTRODUCTION

81
82

At exercise start, the characteristics of the heart rate (HR) kinetics under vagal

83

blockade (12) suggested that sudden withdrawal of vagal tone may occur. This

84

hypothesis may explain the concomitant sudden increase of cardiac output (13, 25).

85

Recently, vagal withdrawal was called upon also to explain the early changes in

86

baroreflex sensitivity upon exercise start (4). If this is so, we should expect that the

87

amplitude of the rapid HR and cardiac output responses would be greater, the

88

stronger is the vagal modulation of heart activity at rest.

89

The experimental evidence, however, is not conclusive under this respect, and

90

several data seem to contradict the vagal withdrawal hypothesis. For instance,

91

although we know that resting vagal activation is greater in supine than in upright

92

position (35, 47, 49), the amplitude of the rapid cardiac output response at exercise

93

onset was found to be smaller in supine than in upright posture (27; 55). On the other

94

hand, vagal activity is reduced and sympathetic activation is increased in acute

95

hypoxia as compared to normoxia (5;18, 23, 57, 58): in spite of this, even in hypoxia

96

HR determined a large fraction of a significant cardiac output response (26). These

97

data represent a serious challenge to the vagal withdrawal hypothesis at exercise

98

onset.

99

The vagal withdrawal hypothesis at exercise onset may also be tested by

100

investigating the neural modulation of the heartbeat under pharmacological blockade

101

of either the vagal or the sympathetic or both branches of the ANS (2, 6, 15, 17, 21,

102

24, 29, 32, 33, 35, 43, 53). The analysis of spontaneous heart rate variability (HRV)

103

demonstrated that vagal blockade reduced the total power (PTOT) of HRV, acting on

104

the reduction of both its high (HF) and low frequency (LF) components. Nevertheless,

105

little attention was given so far to the analysis of HRV during exercise combined with

106

pharmacological blockade. Warren et al. (1997) reported that the powers of both the
4
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107

LF and the HF peaks were by far lower at exercise than at rest under placebo, but

108

they did not find differences under vagal blockade with glycopyrrolate; moreover,

109

esmolol administration provided similar results as placebo. The interpretation of their

110

results was undermined by the type of drug used and their study was limited by the

111

fact that they did not analyse blood pressure variability, another important indirect

112

feature of sympathetic modulation of the cardiovascular system. Polanczyk et al. (42)

113

showed that atropine and propranolol administration did not vary the spectrum

114

components of HRV, contrary to their expectations.

115

If the vagal withdrawal hypothesis was correct, we should predict that, when

116

comparing rest and exercise: i) no differences in PTOT, LF and HF under full vagal

117

blockade would be found; ii) a drastic fall in PTOT, LF and HF under selective 1-

118

sympathetic blockade would occur; iii) no differences in PTOT, LF and HF under

119

simultaneous blockade of the two branches of the ANS would appear. Moreover, we

120

expected that arterial blood pressure variability would not follow the same pattern of

121

response as HRV, because the former reflects more the peripheral sympathetic

122

vascular modulation than the central cardiac modulation.

123

These predictions were tested in the present study, the aim of which was to

124

investigate the effects of vagal blockade, of selective 1-sympathetic blockade and of

125

simultaneous blockade of both branches of the ANS, at rest and during exercise, on

126

HRV and blood pressure variability.

127
128
129

METHODS

130
131

Participants

5
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132

Seven healthy non-smoking young participants volunteered for the

133

experiments. They were (mean ± SD) 24.3 ± 2.6 years old, 181.2 ± 3.1 cm tall and

134

weighed 78.9 ± 6.1 kg. Exclusion criteria were: presence of history of

135

cardiopulmonary disease and regular use of drugs at the time of the study.

136

Participants were instructed to avoid caffeine consumption 24 hours before the visit

137

and to refrain from performing strenuous exercise the day before testing.

138

All participants were preliminarily informed on the design and risks

139

associated with the experiments and they signed a written informed consent. The

140

study was conducted in accordance with the Declaration of Helsinki, and the protocol

141

was approved by the local institutional ethical committee.

142
143

Protocol and measurements

144

The experiments were carried out in the Clinical Physiology Laboratory of the

145

University of Geneva, Switzerland. The volunteers reported to the laboratory on four

146

different days, with at least a 48-hour recovery between visits. Experiments were

147

performed in supine posture, in order to reduce potential mechanical effects related

148

to the remarkable sudden increase in venous return at exercise start upright. After

149

instrumentation, a 20-gauge catheter was placed in the antecubital vein of the right

150

arm to administer drugs. A unique 5-min monitoring at rest preceded a series of three

151

5-min constant-load leg exercises, on cycle ergometer, at 80 watts, to avoid lactate

152

threshold. Between repetitions a 5-min recovery was administered.

153

For the entire duration of the protocol, we obtained continuous recordings of

154

the electrocardiogram (Elmed ETM 2000, Heiligenhaus, Germany), and the arterial

155

pulse pressure profiles, obtained at a fingertip of the left arm by means of a non-

156

invasive cuff pressure recorder (Portapres, FMS, Amsterdam, The Netherlands).

157

The R-R interval (RR) and its reciprocal, HR, were computed beat-by-beat.

158

Systolic and diastolic blood pressure (SAP and DAP, respectively) values were
6
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159

obtained from each pulse pressure profile, using the Beatscope® software package

160

(FMS, Amsterdam, The Netherlands). Beat-by-beat mean arterial pressure (MAP)

161

was computed as the integral mean of each pressure profile, using the same

162

software

163

electrocardiogram plot.

package.

Breathing

frequency

was

also

calculated

from

the

164
165

All the signals were digitalized in parallel by a 16-channel A/D converter

166

(MP150, Biopac Systems, Goleta CA, USA) and stored on a computer. The

167

acquisition rate was 400 Hz.

168

The

protocol
in

was

random

performed
order:

i)

under

control,

four
i.e.

experimental

with

placebo

conditions,

169

administered

infusion,

ii)

170

parasympathetic blockade with atropine administration, ii) selective β1-adrenergic

171

blockade with metoprolol administration, and iv) double blockade of both branches of

172

the ANS with simultaneous atropine and metoprolol administration.

173
174

Drug administration

175

Parasympathetic blockade was achieved by administering atropine in a

176

single 0.04 mg/kg dose (mean 3.06 ± 0.23 mg, range 2.7 – 3.4 mg), which was used

177

in previous studies to attain full vagal blockade (14, 17, 31, 59). The half-life of a

178

single atropine dose is 180 minutes (52) so that, blockade was maintained during the

179

entire duration of each experiment.

180

The 1-adrenergic blockade was attained by using metoprolol tartrate

181

(Loprésor, Novartis, Switzerland). After an initial bolus of 15 mg, metoprolol tartrate

182

was continuously infused in an antecubital vein at a rate of 45 mg per hour, by

183

means of an infusion pump. The efficacy of adrenergic blockade along time was

184

evaluated on a separate session, by analysing the heart rate response following

185

isoprenaline injection, as previously described (14). The correct metoprolol
7
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186

maintenance dose was identified as the dose ensuring an 80% reduction of the HR

187

response to isoprenaline for the entire protocol duration.

188

For

the

experiments
blockade,

the

with

double,

same

simultaneous

189

parasympathetic

atropine

and

190

administration procedure described here above were applied.

sympathetic

metoprolol

dose

and
and

191
192

Data treatment

193

After construction of the time series of RR, SAP and DAP from the continuous

194

recordings of electrocardiogram and pulse pressure profiles, Fast Fourier Transform

195

(FFT) was used to evaluate spontaneous variability of RR, SAP and DAP (35). The

196

data length used was 5 minutes at rest and 3 minutes at exercise. In the latter case,

197

one repetition, that with the most stable and cleanest trace, was analysed. The total

198

power (PTOT) (0.0-0.5 Hz) of RR, SAP and DAP variabilities, corresponding to

199

variance, was initially computed. Subsequently, the powers and frequencies of LF

200

(0.03–0.14 Hz) and HF (0.15–0.5 Hz) components of the power spectrum were

201

computed and expressed in absolute units (ms2). The very low frequency component

202

was neglected. The LF/HF ratio was also calculated. Normalized LF and HF (LFnu

203

and HFnu, respectively) were computed as:

204
205

LF×100
Ptot−VLF

(1)

and expressed in normalized units (28).

206

The spontaneous baroreflex sensitivity (BRS, expressed in ms mmHg-1) was

207

estimated from SAP and RR by means of the sequence method (3). Sequences of at

208

least three heartbeats, corresponding to an increase or decrease in SAP and

209

identifying a consensual change in RR interval, were selected. Linear regression

210

analysis was applied on these sequences and the calculated slope was retained.

211

BRS was then calculated as the mean of the slopes of all sequences per each

8
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212

participant in each condition. Only sequences showing a coefficient of determination

213

of at least 0.85 were analysed.

214

Spectral analysis and BRS were performed on Matlab® environment as previously

215

described (41). Breathing Frequency was calculated with the ECG-Derived-

216

Respiration method used by Moody et al. (30).

217
218
219

Statistics

220

Data are reported as group means ± standard deviation. The effects of

221

medication and exercise type on the main outcomes were analysed by 2-way

222

ANOVA for repeated measurements. When applicable, a Tukey post-hoc test was

223

used to locate significant differences. Differences were considered significant if

224

p<0.05. All data were analysed with Statistica 12 © (StatSoft, Inc., Tulsa, OK).

225
226

RESULTS

227

All participants successfully completed the study maintaining a normal sinus

228

beat along the four experimental conditions (no arrhythmic beats were observed).

229

The mean values of measured and calculated variables at rest and during exercise

230

for all conditions are reported in Table 1. At rest, in control condition, HR was 62.7 ±

231

8.5 min-1. Under sympathetic blockade, no significant differences with respect to

232

control were observed. Under atropine, it was significantly higher than in control and

233

under metoprolol. Under double blockade, it was higher than in control and under

234

metoprolol, but lower than under atropine. During exercise, in control condition, HR

235

was 105.0 ± 12.4 min-1, and was higher under metoprolol, atropine and double

236

blockade than in control. With respect to the corresponding values at rest, HR during

237

exercise increased in all conditions except double blockade.
9
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238

At rest, in control condition SAP was 112.0±9.5 mmHg and DAP was 55.0±9.6

239

mmHg. With respect to control, no differences were observed for either SAP or DAP

240

with any investigated pharmacological treatment, although with double blockade,

241

DAP tended to be higher than in control and was significantly higher than under

242

metoprolol. MAP was 74.0±8.6 mmHg in control and did not differ in the three

243

investigated pharmacological conditions, except that it was higher under double

244

blockade than with metoprolol. Breathing frequency was 0.23±0.06 Hz in control and

245

did not change in the three conditions. At exercise, in control condition, SAP was

246

138.5±17.5 and DAP was 60.9±7.5 mmHg. With respect to control, SAP was

247

significantly lower under the three pharmacological conditions. No differences were

248

observed for DAP. MAP was 86.8±9.9 mmHg in control and did not vary significantly

249

among conditions. With respect to the corresponding values at rest, MAP during

250

exercise was higher only in control. Breathing frequency was 0.42±0.07 Hz in control

251

and did not change in the three other conditions.

252

HRV data are shown in Table 2. Examples of HRV spectra are shown in

253

Figure 1. At rest, with respect to control, PTOT was not affected by metoprolol

254

administration, but it was largely and significantly decreased under atropine and

255

double blockade, due to drastically lower values of both LF and HF powers. No

256

differences between atropine and double blockade were found. The same was the

257

case at exercise, although the difference were much smaller than at rest, because,

258

when moving from rest to exercise, PTOT was drastically reduced in control and

259

under metoprolol. No differences for LF and HF powers between sympathetic

260

blockade and control, or between atropine and double blockade, were observed.

261

At rest, the LF/HF ratio at rest was unaffected by drug treatment, the only

262

significant difference being between atropine and double blockade. The same was

263

the case for LFnu. No differences were observed concerning HFnu. At exercise, the

264

LF/HF ratio did not differ under metoprolol or atropine with respect to control, but it
10
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265

was lower under double blockade than in control and in the other pharmacological

266

conditions. The same was the case for LFnu. Coherently, HFnu was higher in double

267

blockade than in any other condition.

268

All data concerning spontaneous SAP and DAP variability are shown in Table

269

3. At rest, concerning SAP, no differences among conditions were observed for PTOT.

270

Concerning the LF power, no differences between sympathetic blockade and control

271

were found, but it was lower under atropine and double blockade than in control and

272

sympathetic blockade. The HF power in atropine and double blockade was lower

273

than in control and under metoprolol, although for the latter the level of significance

274

was not attained. During exercise, PTOT was lower in all three investigated

275

pharmacological conditions than in control, but no differences among conditions were

276

observed for both the LF and the HF powers. In control and under atropine, the LF

277

power was higher at exercise than at rest. The LF/HF ratio was unchanged in all

278

conditions.

279

At rest, concerning DAP, no changes in PTOT were found in any

280

pharmacological condition with respect to control. The HF power did not vary among

281

conditions, while the LF power was lower in atropine and double blockade than in

282

control. The LF/HF ratio was lower in all conditions than in control. During exercise,

283

there were no significant differences among conditions or with respect to the same

284

condition at rest.

285

The BRS values at rest and exercise are shown in Figure 2. At rest, BRS was

286

significantly lower under atropine and under double blockade than in control and

287

under sympathetic blockade, which in turn did not differ between them. During

288

exercise, BRS under atropine and double blockade was lower than in control and

289

under sympathetic blockade. BRS was lower at exercise than at rest in all conditions

290

except double blockade.

291
11
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292

DISCUSSION

293
294

The analysis of spontaneous heart rate variability at rest showed that: 1.

295

atropine administration drastically reduced PTOT, due to the fall of both LF and HF

296

powers, with respect to control; 2. simultaneous double blockade with atropine and

297

metoprolol provided the same results as atropine administration only; 3. metoprolol

298

administration had no effects on heart rate variability.

299

When moving from rest to exercise, our results showed that: 1. no differences

300

in PTOT, LF and HF appeared under atropine and under simultaneous atropine and

301

metoprolol administration with respect to rest; 2. PTOT, and the LF and HF powers,

302

were decreased by the same extent under metoprolol as in control. However, during

303

exercise, PTOT, and the LF and HF powers were lower under atropine and double

304

blockade than in control or with metoprolol.

305

These results are in line with the predictions made, and thus do not allow

306

refutation of the vagal withdrawal hypothesis, but rather reinforce it. Although, taken

307

separately, similar consistent results can be found in the previous literature (2, 6, 8,

308

10, 11, 15, 17, 21, 24, 29, 32, 33, 35, 43, 44), this is the first time that a complete

309

picture of the role of the autonomic nervous system in determining heart rate

310

variability in rest and exercise was obtained.

311
312

Heart rate variability

313

The significant increase in HR after atropine administration is in line with

314

previous studies (9, 21, 22, 48, 50) and was opposed by the observation that, after

315

metoprolol administration, despite a slight decrease, HR did not change significantly

316

compared to control. These results were similar in size to those obtained in a

317

previous study with the same drug (48). However, they are at variance with those of

318

other studies, carried out in upright posture, showing a significant HR reduction at
12
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319

rest with beta-blockade (11, 14, 15, 19). In supine posture, the predominance of

320

vagal modulation of HR (20, 35) may explain the lack of HR changes with metoprolol.

321

Concerning HRV, metoprolol failed in changing PTOT, LF and HF at rest,

322

indicating that a selective blockade of cardiac -adrenergic receptors has no effects

323

on spontaneous HR oscillations. This suggests that the sympathetic outflow to the

324

heart may not be the main determinant of HRV, although the PTOT values under

325

double blockade appear lower (just a tendency) than under atropine. These results

326

for PTOT, although in agreement with those of some previous studies (15, 53), are in

327

contrast with those by Cogliati et al. (11), who showed an increase in PTOT under

328

atenolol, supporting the idea that the pattern was mostly due to an increase in the HF

329

peak. This finding suggested stronger cardio-respiratory coupling under atenolol than

330

in control. Comparable results were obtained by others (40) using propranolol.

331

Spontaneous HR oscillations were almost suppressed after atropine

332

administration, as previously found (8, 15, 21, 29, 32, 33, 53), supporting the notion

333

that parasympathetic outflow to the heart is the major determinant of HRV in resting

334

humans. This was so also under simultaneous sympathetic and vagal blockade,

335

indicating that suppression of the parasympathetic modulation of the heartbeat was

336

the most important determinant of the present results. Breathing frequency did not

337

change in the three conditions, being obviously higher at exercise than at rest. This

338

implies that changes in HF power were not due to any change in breathing

339

frequency.

340

Coherently, in the present study, passing from rest to exercise implied a large

341

fall in LF and HF powers in control and under metoprolol. Conversely, under atropine

342

and double blockade, in which a suppression of the vagal modulation of HR was

343

obtained already at rest, no changes were found at exercise with respect to rest.

344

These results demonstrate that the well-known fall of HRV, which is usually observed

345

during exercise (37), is essentially a consequence of the withdrawal of the vagal
13
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346

outflow to the heart occurring at exercise onset (12, 25), as hypothesized. As such,

347

our results suggest that vagal withdrawal is incomplete at the investigated powers,

348

because the LF and HF powers during exercise were still higher in control than with

349

atropine or double blockade, the two conditions in which a full blockade of muscarinic

350

receptors was attained. On the other hand, the fact that passing from rest to exercise

351

generated comparable results with metoprolol as in control, is coherent with the

352

reported decrease of the LF peak in humans (37, 39). These data are in contrast with

353

the generally accepted notion that, during exercise, the degree of sympathetic

354

activation increases (46, 54) and the modulation of the heartbeat by the sympathetic

355

efferents becomes predominant (38, 45). This may mean that HRV in exercise does

356

not reflect the degree of ongoing sympathetic activation.

357

When we look at the normalized variables at rest, none of the investigated

358

drugs could change the LF/HF significantly with respect to control: this reflects the

359

finding that the effects of drug administration on the LF and HF powers at rest were

360

of the same size. In contrast, during exercise, there was a tendency toward a lower

361

HF power than LF power. Yet this tendency, though not significant, was such as to

362

provide, at exercise compared to rest, significantly lower HFnu values in control and

363

under sympathetic blockade (only a tendency in A and in DB). Consequently, LF/HF

364

ratio resulted higher at exercise than at rest, at least in these two cases.

365

In the context of the present hypothesis, this would suggest that the

366

withdrawal of vagal tone at exercise onset might have had greater effects on the HF

367

than on the LF component of HRV. Alternatively, the relative increase of the LF

368

component of RR variability may suggest an increase of the cardiac sympathetic

369

modulation. Nevertheless, LFnu in double blockade was significantly lower and HFnu

370

significantly higher than in control, despite the lack of differences in the LF/HF ratio.

371

This may be due to the non-autonomic effect of an increase in ventilation that is

372

reflected on HRV through changes in venous return during exercise. A similar
14
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373

condition can be observed in a neurodegenerative disease such as the pure

374

autonomic failure. This condition is characterized by both a cardiac sympathetic and

375

parasympathetic denervation leading to PTOT values mimicking high dosage atropine

376

administration (16), in which a HF component of HRV, non-autonomic in origin, is

377

present (39). These apparently contradictory results prevent us from arriving at clear-

378

cut conclusions concerning the mechanisms at the basis of relative powers in this

379

study.

380
381

Blood pressure variability

382

Arterial blood pressure at rest was unaffected by drug administration. The fact

383

that atropine did not act on systemic blood pressure, in agreement with previous

384

studies (15, 21), is coherent with the notion that there is no cholinergic innervation in

385

most regional circulations. On the other hand, metoprolol is a selective blocker of 1-

386

adrenergic receptors that are expressed specifically in the heart, not in arterioles, so

387

that it is not expected to induce changes in blood pressure.

388

Coherently, SAP variability was much less affected by atropine and double

389

blockade than HRV. According to Zhang et al. (61), who investigated spontaneous

390

blood pressure variability under ganglionic blockade with Trimethaphan, the HF peak

391

of blood pressure variability is mediated by mechanical effects due to the breathing

392

cycle and cardiac filling: if this is so, one would not expect effects of any of the drugs

393

used in this study on the HF power for blood pressure. In fact, the changes in HF

394

power due to drug administration in the present study were much smaller than for

395

HRV, although significant under atropine and double blockade. Zhang et al. (61) also

396

attributed the LF power of blood pressure variability to either sympathetic activity or

397

intrinsic vascular rhythmicity: if this is so, no changes in LF were to be found with

398

atropine, metoprolol or double blockade: in fact, we found much smaller differences

399

in LF power due to drug administration for blood pressure variability than for HRV.
15
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400

Yet these changes were consensual with those of HF power, being significant under

401

atropine and double blockade. These effects might have been an indirect

402

consequence of the role that the autonomic nervous system may play in modulating

403

the dynamic relationship between HRV and blood pressure variability (7, 61), with an

404

involvement of its parasympathetic branch.

405

Most remarkable are the differences observed when passing from rest to

406

exercise: the LF power for SAP increased in control, as expected (37, 39), and with

407

atropine, but not with metoprolol and in double blockade. This indicates that the

408

increase in LF power for SAP may be a consequence of increased sympathetic

409

modulation during exercise. No effects were observed under any drug on the HF

410

power: this means that the HF power of SAP is independent of the activity of the two

411

branches of the ANS. The lack of exercise effects on HF power under drug

412

stimulation explains why the PTOT did not differ significantly at exercise with respect

413

to rest under atropine.

414

DAP variability was unaffected by drug administration: this suggests that the

415

exercise effect on the LF power of SAP, related to a selective blockade of 1

416

adrenergic receptors, is mediated by a central (cardiac) rather than a peripheral

417

(arteriolar muscle vasodilation) action of the sympathetic branch of the ANS.

418
419

Baroreflex sensitivity

420

At rest, BRS was drastically lower under atropine and double blockade than in

421

control. This observation was consistent with what we observed for the LF peak of

422

blood pressure variability: reduced under atropine and double blockade, unchanged

423

under metoprolol, with respect to control. Coherently, when comparing rest with

424

exercise in a given condition, BRS decreased in control and under metoprolol, but did

425

not change under atropine and double blockade. These results on BRS appear in

426

agreement with previous observations (1, 11, 56). Bringard et al. (4) postulated that
16
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427

BRS is mainly modulated by the parasympathetic efferent branch on the ANS. These

428

data support this hypothesis. Muscarinic receptors do not modulate smooth muscle

429

tone

430

parasympathetic effect on arterial blood pressure variability indexes must be indirect.

431

Based on the present results, we speculate that baroreflexes may participate in the

432

modulation of the LF power of arterial blood pressure. The reduction of BRS

433

observed during exercise (51) support the idea of alfa-index changes as previously

434

reported (36). In the present study, the BRS reduction at exercise was observed only

435

in control and with metoprolol, but not with atropine and double blockade. This finding

436

reinforces the notion that withdrawal of vagal tone is responsible for the fall of BRS at

437

exercise onset (4, 34). Coherently, no differences in BRS among the four

438

investigated conditions were observed during exercise.

in

most

arterioles,

including

those

of

skeletal

muscles.

Thus,

the

439
440

Study limitations

441

A limitation of this study may be suggested by the lack of differences between

442

control and metoprolol, as this may also suggest that the 1-adrenergic blockade

443

might have been incomplete. It is of note, however, that we used the same dose and

444

followed the same procedure of metoprolol administration as in a previous study (14)

445

in upright posture, which showed a significant resting HR decrease both in normoxia

446

and in acute hypoxia at rest as at exercise. Moreover, we observe that the

447

isoprenaline test provided unambiguous evidence of quasi-complete 1-adrenergic

448

blockade.

449

Another possible limiting factor is related to the fact that HR rate differed

450

remarkably among conditions. This may affect the HRV indexes in time domain per

451

se (59), thus possibly undermining the relation to the action of the autonomic nervous

452

system.

453
17
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454

CONCLUSION

455

The results of this study support the tested hypothesis that vagal suppression

456

is responsible of the disappearance of the spontaneous HRV during exercise. The

457

observed effects on arterial blood pressure variability are indirectly related to the

458

action of the administered drugs, supporting the notion that blood pressure and HRV

459

are

460

physiological mechanisms

only

partially-associated

phenomena,

possibly

controlled

by

different

461
462
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636
637

Table 1: Mean steady state values for the cardiovascular variables monitored during rest (R)

638

and exercise (E) in the four experimental conditions: Control, Atropine, Metoprolol, and

639

Double Blockade.

Control

Metoprolol

Atropine

R

62.67±8.47

59.58±7.11#§

111.17±17.75*§

Double
Blockade
93.71±5.48*

E

105.04±12.39

93.53±8.17#

135.04±20.56*

103.19±8.06#

R

985.3 ± 185.7

1017.7 ± 104.4#

548.6 ± 79.5 *§

642.1 ± 38.2 *

E

577.9 ± 66.2

645.3 ± 51.3#

455.9 ± 89.3*

584.2 ± 41.1#

R

111.97±9.52

109.75±13.89

112.96±11.83

119.48±14.29

E

138.51±17.53

113.58±15.21*

108.73±15.94*

107.70±14.76*

R

54.95±9.64

48.96±10.81§

60.95±9.10

66.16±8.43

E

60.94±7.48

53.35±13.55

54.21±7.72

54.34±6.92

R

73.95±8.59

69.22±10.42§

78.28±7.76

83.93±7.78

E

86.79±9.88

73.42±13.53

72.58±10.03

72.13±9.41

BRS (ms

R

25.74 ± 11.28

27.42 ± 8.51#

2.17 ± 1.06 *§

3.00 ± 0.92 *

mmHg-1)

E

2.59 ± 1.76

3.17 ± 0.62 #

0.85 ± 0.31*

2.13 ± 0.44

R

0.23 ± 0.06

0.21 ± 0.06

0.29 ± 0.04

0.23 ± 0.07

E

0.42 ± 0.07

0.39 ± 0.04

0.40 ± 0.04

0.41 ± 0.07

Measured
variables
HR (min-1)

RR (ms)

SAP (mmHg)

DAP (mmHg)

MAP (mmHg)

BF (Hz)

640
641

Values are means ± SD. HR: heart rate; RR: R-R interval; SAP: systolic arterial pressure;

642

DAP: diastolic arterial pressure; MAP: mean arterial pressure; BRS: spontaneous baroreflex

643

sensitivity. BF: breathing frequency.

644

N=7; 2-way ANOVA for repeated measurements; p<0.05; *: significantly different from

645

Control. #: significantly different from Atropine. §: significantly different from Double

646

Blockade. In bold: Exercise significantly different from Rest.
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647

Table 2: Mean and standard deviations of all parameters calculated by means of heart rate

648

variability in the four investigated conditions: Control, Atropine, Metoprolol, and Double

649

Blockade.

Control

Metoprolol

Atropine

Double blockade

R

6351.4 ± 4476.4

7883.2 ± 5965.9

22.5 ± 13.8*●

12.9 ± 4.9*●

E

185.4 ± 77.1

93.6 ± 30.9*

10.1 ± 3.3*●

14.8 ± 4.7*●

R

1717.5 ± 1290.6

2711.9 ± 2061.8

1.5 ± 1.2*●

1.1 ± 0.5*●

E

40.6 ± 29.3

41.3 ± 29.3

1.7 ± 1.4*●

1.6 ± 1.5*●

R

1441.0 ± 1296.1

2552.3 ± 2245.0

0.9 ± 0.5*●

2.6 ± 0.8*●

E

10.8 ± 7.8

11.2 ± 9.2

0.3 ± 0.13*

3.1 ± 1.6*●

R

1.4 ± 1.0

1.4 ± 0.8

1.8 ± 0.9

0.5 ± 0.3

E

4.1 ± 2.0

4.0 ± 2.0

4.0 ± 2.6

0.3 ± 0.1*●

R

46.8 ± 19.3

46.1 ± 14.7

57.7 ± 28.2

25.9 ± 13.8

E

69.6 ± 16.5

65.3 ± 21.2

61.6 ± 22.7

12.7 ± 8.0*●

R

51.1 ± 18.3

51.1 ± 15.4

38.3 ± 26.9

62.6 ±15.6

E

15.5 ± 8.7

17.4 ± 5.0

22.6 ± 14.4

45.5 ± 23.5*●

Heart Rate variability

ABSOLUTE
VALUES
PTOT (ms2Hz-1)

-1

LF (ms2Hz )

-1

HF (ms2Hz )

RELATIVE
VALUES
LF/HF

LFnu (%)

HFnu (%)

650
651

Values are means ± SD. PTOT: total power. LF: low frequency power. HF: high frequency

652

power. LF/HF: low–to–high frequency ratio; LFnu, relative low frequency power; HFnu,

653

relative high frequency power. R: Rest. E: Exercise.

654

N=7; 2-way ANOVA for repeated measurements; p<0.05; *: significantly different from

655

Control. ●: significantly different from Metoprolol. : significantly different from Atropine. In

656

bold: Exercise significantly different from Rest
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657

Table 3: Parameters resulting from the analysis of spontaneous variability of systolic and

658

diastolic arterial pressures in the four investigated conditions: Control, Atropine, Metoprolol,

659

and Double Blockade.

SAP variability
PTOT (ms2Hz-1)

LF (ms2Hz-1)

HF (ms2Hz-1)

Control

Metoprolol

Atropine

Double Blockade

R

25.70 ± 11.52

26.91 ± 15.50

16.99 ± 17.77

15.63 ± 8.19

E

70.83 ± 41.42

29.07 ± 12.24*

28.09 ± 6.77*

17.46 ± 7.00*

R

7.03 ± 3.60

4.96 ± 1.90

1.55 ± 0.64*●

2.09 ± 1.38*●

E

18.68 ± 17.97

5.51 ± 1.52

10.93 ± 6.15*●

5.80 ± 2.90*

R

4.04 ± 3.21

2.57 ± 1.79

1.20 ± 0.45*

1.09 ± 0.67*

E

5.49 ± 4.20

5.48 ± 3.96

3.29 ± 1.80

2.48 ± 0.93

R

2.27 ± 1.07

2.36 ± 1.09

1.46 ± 0.70

2.32 ± 1.54

E

2.61 ± 1.39

1.87 ± 1.32

3.46 ± 2.39

2.17 ± 0.67

R

9.65 ± 6.06

9.01 ± 3.47

4.64 ± 3.03

5.10 ± 2.32

E

7.63 ± 2.56

5.52 ± 2.56

3.92 ± 1.00

4.90 ± 3.40

R

3.54 ± 2.57

2.56 ± 1.17

0.77 ± 0.52*

0.97 ± 0.67*

E

2.70 ± 1.80

1.97 ± 0.86

1.63 ± 0.48

1.11 ± 0.31

R

2.22 ± 2.77

1.88 ± 2.10

0.40 ± 0.20

0.46 ± 0.52

E

1.66 ± 1.25

1.13 ± 0.75

0.89 ± 0.52

0.92 ± 0.50

R

3.65 ± 1.26

2.40 ± 1.21*

2.03 ± 1.26*

3.03 ± 1.48*

E

3.00 ± 2.53

1.69 ± 0.98

2.05 ± 0.73

1.53 ± 0.63

LF/HF

DAP variability
PTOT (ms2Hz-1)

LF (ms2Hz-1)

HF (ms2Hz-1)

LF/HF
660
661

Values are means ± SD. PTOT: total power. LF: low frequency power. HF: high frequency

662

power. LF/HF: low–to–high frequency ratio. R: Rest. E: Exercise.

663

N=7; 2-way ANOVA for repeated measurements; p<0.05; *: significantly different from

664

Control. ●: significantly different from Metoprolol; : significantly different from Atropine. In

665

bold: Exercise significantly different from Rest
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666

Figure 1: Heart Rate Variability (HRV) spectrum resulting from the experiments which the

667

shown HRV segments belong to left column: Rest; right column: Exercise; first row: Control;

668

second row: Atropine; third row: Metoprolol; fourth row: Double blockade. N=7; X axis:

669

frequency (Hz). Y axis: RR power (ms2/Hz). Note: differences in Y scales. C: Control. A:

670

Atropine. M: Metoprolol DB: Double blockade.

671

Figure 2: Mean values ± SD of BRS in each investigated condition (control / atropine /

672

metoprolol / double blockade) at rest and during exercise. BRS: Spontaneous baroreflex

673

sensitivity. N=7; 2-way ANOVA for repeated measurements; p<0.05: *: significantly different

674

from CTRL. #: significantly different from DB. §: significantly different from ATR. $:

675

significantly different from the same condition at rest.

676

28

Downloaded from www.physiology.org/journal/jappl by Alessandra Adami (131.128.072.082) on October 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.

Downloaded from www.physiology.org/journal/jappl by Alessandra Adami (131.128.072.082) on October 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.

Downloaded from www.physiology.org/journal/jappl by Alessandra Adami (131.128.072.082) on October 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.

